205 related articles for article (PubMed ID: 33173483)
1. Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report.
Marshall S; Kizuki A; Kitaoji T; Imada H; Kato H; Hosoda M; Ishikawa M; Sakura H
Case Rep Oncol; 2020; 13(3):1185-1190. PubMed ID: 33173483
[TBL] [Abstract][Full Text] [Related]
2. Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and ipilimumab: A case report.
Iesaka H; Kameda H; Miya A; Nomoto H; Cho KY; Nakamura A; Abe T; Shinohara N; Atsumi T
Medicine (Baltimore); 2023 Dec; 102(51):e36664. PubMed ID: 38134115
[TBL] [Abstract][Full Text] [Related]
3. Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review.
Zeng MF; Chen LL; Ye HY; Gong W; Zhou LN; Li YM; Zhao XL
Medicine (Baltimore); 2017 Nov; 96(44):e8426. PubMed ID: 29095280
[TBL] [Abstract][Full Text] [Related]
4. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report.
Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T
BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163
[TBL] [Abstract][Full Text] [Related]
5. A case of nivolumab-induced isolated adrenocorticotropic hormone (ACTH) deficiency.
Sato Y; Tanaka Y; Hino M; Seike M; Gemma A
Respir Med Case Rep; 2019; 26():223-226. PubMed ID: 30740300
[TBL] [Abstract][Full Text] [Related]
6. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
[TBL] [Abstract][Full Text] [Related]
7. Isolated adrenocorticotropic hormone deficiency induced by nivolumab treatment for advanced gastric cancer.
Namikawa T; Shimizu S; Yokota K; Tanioka N; Fukudome I; Munekage M; Uemura S; Maeda H; Kitagawa H; Hanazaki K
Clin J Gastroenterol; 2021 Aug; 14(4):988-993. PubMed ID: 33715100
[TBL] [Abstract][Full Text] [Related]
8. [A Case of Isolated ACTH Deficiency Induced by Nivolumab in a Patient with Gastric Cancer Metastasis of the Peritoneum].
Mashita N; Otake K; Nonogaki A; Saito H; Nakamura M; Yamanaka M; Tobinaga J; Ishigure K
Gan To Kagaku Ryoho; 2019 Dec; 46(12):1879-1882. PubMed ID: 31879407
[TBL] [Abstract][Full Text] [Related]
9. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation.
Sekizaki T; Kameda H; Oba C; Yong Cho K; Nakamura A; Miyoshi H; Osawa T; Shinohara N; Atsumi T
Endocr J; 2019 Oct; 66(10):937-941. PubMed ID: 31217401
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Thyroid Dysfunction and Isolated Adrenocorticotropin Deficiency after Nivolumab Therapy for Malignant Melanoma].
Nishio K; Okada Y; Kurozumi A; Tanaka Y
J UOEH; 2021; 43(1):97-102. PubMed ID: 33678791
[TBL] [Abstract][Full Text] [Related]
11. Hypothyroidism With ACTH Deficiency During Pembrolizumab Therapy for Lung Cancer: Case Report and Literature Review.
Hashinokuchi A; Haro A; Minagawa R; Haruta Y; Kawano H; Suehiro T; Sugimachi K
Cancer Diagn Progn; 2023; 3(4):498-503. PubMed ID: 37405219
[TBL] [Abstract][Full Text] [Related]
12. Nivolumab-induced hypothyroidism followed by isolated ACTH deficiency.
Martins Machado C; Almeida Santos L; Barroso A; Oliveira MJ
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31466960
[TBL] [Abstract][Full Text] [Related]
13. Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab.
Kitajima K; Ashida K; Wada N; Suetsugu R; Takeichi Y; Sakamoto S; Uchi H; Matsushima T; Shiratsuchi M; Ohnaka K; Furue M; Nomura M
Jpn J Clin Oncol; 2017 May; 47(5):463-466. PubMed ID: 28334791
[TBL] [Abstract][Full Text] [Related]
14. Nivolumab-induced hypothyoidism with consequent hypothyroid related myopathy.
Johnson ED; Kerrigan K; Butler K; Patel SB
J Oncol Pharm Pract; 2020 Jan; 26(1):224-227. PubMed ID: 30880569
[TBL] [Abstract][Full Text] [Related]
15. Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo-progression in clear cell renal cell carcinoma: A case report.
Furubayashi N; Negishi T; Uozumi T; Takamatsu D; Shiraishi K; Hirose D; Nakamura M
Mol Clin Oncol; 2019 Feb; 10(2):304-308. PubMed ID: 30680212
[TBL] [Abstract][Full Text] [Related]
16. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
Thapi S; Leiter A; Galsky M; Gallagher EJ
J Immunother Cancer; 2019 Sep; 7(1):248. PubMed ID: 31511065
[TBL] [Abstract][Full Text] [Related]
17. Adrenal Insufficiency and Thyrotoxicosis Following Combined Immune Checkpoint Inhibitor Use: A Case Report and Literature Review.
Fukushima K; Kitayama S; Sazuka M; Kodera R; Oba K; Toyoshima K; Chiba Y; Yamamoto H; Araki A; Tamura Y
Cureus; 2024 May; 16(5):e60850. PubMed ID: 38910605
[TBL] [Abstract][Full Text] [Related]
18. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
[TBL] [Abstract][Full Text] [Related]
19. Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody-insight into the pathogenesis of autoimmune endocrinopathy.
Okahata S; Sakamoto K; Mitsumatsu T; Kondo Y; Noso S; Ikegami H; Shiba T
Endocr J; 2019 Apr; 66(4):295-300. PubMed ID: 30814440
[TBL] [Abstract][Full Text] [Related]
20. Painless Thyroiditis and Fulminant Type 1 Diabetes Mellitus in a Patient Treated with an Immune Checkpoint Inhibitor, Nivolumab.
Sakurai K; Niitsuma S; Sato R; Takahashi K; Arihara Z
Tohoku J Exp Med; 2018 Jan; 244(1):33-40. PubMed ID: 29343652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
